Study details
Enrolling now
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
University of California, Davis
NCT IDNCT06389123ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
40
Study length
about 4 years
Ages
18+
Locations
1 site in CA
About this study
This trial is testing a new treatment, [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G, in people with metastatic cancer. The goal is to see if this treatment is safe and effective.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G
PhasePhase 1
Primary goal[68Ga]Ga DOTA-5G PET/CT imaging
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: [68Ga]Ga DOTA-5G PET/CT imaging